☰

Antoinette E. Nibbs - Publications

Affiliations: 
2006-2012 Chemistry Northwestern University, Evanston, IL 
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Badr CE, da Hora CC, Kirov AB, Tabet E, Amante R, Maksoud S, Nibbs AE, Fitzsimons E, Boukhali M, Chen JW, Chiu NHL, Nakano I, Haas W, Mazitschek R, Tannous BA. Obtusaquinone is a cysteine modifying compound that targets Keap1 for degradation. Acs Chemical Biology. PMID 32338864 DOI: 10.1021/acschembio.0c00104  0.318
2018 Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, et al. Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454. PMID 29934502 DOI: 10.1038/S41467-018-04465-5  0.777
2015 McDonald BR, Nibbs AE, Scheidt KA. A biomimetic strategy to access the silybins: total synthesis of (-)-isosilybin A. Organic Letters. 17: 98-101. PMID 25517432 DOI: 10.1021/Ol503303W  0.52
2013 Yang KS, Nibbs AE, Türkmen YE, Rawal VH. Squaramide-catalyzed enantioselective Michael addition of masked acyl cyanides to substituted enones. Journal of the American Chemical Society. 135: 16050-3. PMID 24090310 DOI: 10.1021/Ja409012Q  0.308
2012 Nibbs AE, Scheidt KA. Asymmetric Methods for the Synthesis of Flavanones, Chromanones, and Azaflavanones. European Journal of Organic Chemistry. 2012: 449-462. PMID 22876166 DOI: 10.1002/Ejoc.201101228  0.527
2012 Xu L, Farmer R, Huang X, Pruell S, Voll E, Pavese J, Valsecchi M, Biddle M, Nibbs A, Avram M, Scheidt KA, Bergan RC. Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752. DOI: 10.1158/1538-7445.Am2012-4752  0.77
2012 Krishna SN, Luan C, Minasov G, Shuvalova L, Farmer RL, Nibbs A, Scheidt KA, Anderson WF, Bergan RC. Abstract 4751: Structure and inhibition of mitogen-activated protein kinase kinase 4 (MEK4): A prostate cancer pro-invasion protein Cancer Research. 72: 4751-4751. DOI: 10.1158/1538-7445.Am2012-4751  0.765
2011 Xu L, Farmer R, Huang X, Valsecchi M, Pavese J, Voll E, Biddle M, Nibbs A, Pruell S, Avram M, Scheidt K, Bergan RC. Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C177  0.765
2011 Farmer RL, Biddle MM, Nibbs AE, Huang X, Xu L, Bergan RC, Scheidt KA. Erratum: Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression (ACS Medicinal Chemistry Letters (2010) 1 (400-405) DOI: 10.1021/ml100110x) Acs Medicinal Chemistry Letters. 2. DOI: 10.1021/Ml1003102  0.762
2010 Farmer RL, Biddle MM, Nibbs AE, Huang X, Bergan RC, Scheidt KA. Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression. Acs Medicinal Chemistry Letters. 1: 400-405. PMID 21116437 DOI: 10.1021/Ml100110X  0.757
2010 Xu L, Farmer R, huang x, Pavese J, Voll E, Irene O, Biddle M, Nibbs A, Valsecchi M, Scheidt K, Bergan R. Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B58  0.769
2009 Nibbs AE, Baize AL, Herter RM, Scheidt KA. Catalytic asymmetric alkylation of substituted isoflavanones. Organic Letters. 11: 4010-3. PMID 19658430 DOI: 10.1021/Ol901676F  0.581
Show low-probability matches.